Wednesday, August 17th | 20 Av 5782

August 2, 2017 10:42 am

Israel Must Be Boycotted — Unless It Saves Our Lives

avatar by Elder of Ziyon


Saeb Erekat. Photo: Wikimedia Commons.

We’ve seen before how BDS activists talk big about boycotting Israel — which really means that everyone else must boycott Israel.

We know, for example, how Omar Barghouti wants everyone to boycott Israeli universities, while he attended (attends?) one. We’ve also seen how BDS groups happily use Israeli website technology — and even try to justify it.

Now we can add Saeb Erekat to this list. Erekat has publicly called for BDS policies to be adopted in Europe. But now he needs medical help in Israel, and he doesn’t hesitate to use it:

Palestinian Authority chief negotiator and secretary general of the Palestine Liberation Organization Saeb Erekat has a serious lung disease and is currently on the waiting list for a transplant in Israel and the US, according to a report Tuesday on the Ynet news site.

Erekat, 62, was diagnosed with pulmonary fibrosis over a year ago and had been on medications that were effectively treating the disease. However, the drugs stopped working several months ago, and his condition has since deteriorated dramatically.

The chief PA negotiator has been receiving additional treatment at a hospital in central Israel, but doctors have warned that his condition cannot improve without an immediate transplant, the report said.

Suddenly, Israeli goods and services seem to be not so terrible!

Erekat could go to Europe or an Arab country to get the transplant and treatment. But — you guessed it —  he chooses Israel.

The hypocrisy doesn’t end there. The Palestinian Authority has recently slashed the number of medical permits for Gazans to get treated in Israel. Yet Erekat, of course, has to get the best medical care possible.

The opinions presented by Algemeiner bloggers are solely theirs and do not represent those of The Algemeiner, its publishers or editors. If you would like to share your views with a blog post on The Algemeiner, please be in touch through our Contact page.

Share this Story: Share On Facebook Share On Twitter

Let your voice be heard!

Join the Algemeiner

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.